Correction: Everolimus (EVE) and exemestane (EXE) in...

Oncotarget 2018 / 10 Vol. 9; Iss. 77

Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

Cazzaniga, Marina, Verusio, Claudio, Ciccarese, Mariangela, Fumagalli, Alberto, Sartori, Donata, Ancona, Chiara, Airoldi, Mario, Moretti, Gabriella, Ficorella, Corrado, Arcangeli, Valentina, Diodati,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Journal:
Oncotarget
DOI:
10.18632/oncotarget.26213
Date:
October, 2018
File:
PDF, 680 KB
2018
Conversion to is in progress
Conversion to is failed